Trials / Recruiting

RecruitingNCT06780410

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

A Phase III Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid in Patients with Hyperlipidemia Not Adequately Controlled by Statins

Status: Recruiting
Phase: Phase 3
Study type: Interventional
Enrollment: 240 (estimated)

Sponsor: Gan & Lee Pharmaceuticals. · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Conditions

Primary Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Bempedoic Acid Tablet	Once daily, oral
DRUG	Placebo	Once daily, oral

Timeline

Start date: 2024-12-20
Primary completion: 2025-10-01
Completion: 2025-10-01
First posted: 2025-01-17
Last updated: 2025-01-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06780410. Inclusion in this directory is not an endorsement.